Skip to main content

Advertisement

Log in

Impact of Nonosseous Findings on 18F-NaF PET/CT in a Patient with Ductal Breast Carcinoma

  • Case Report
  • Published:
Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

18F-NaF was used as a bone-seeking PET tracer for skeletal imaging until the introduction of the widely available 99mTc-labeled bone agents. However, there is renewed clinical interest in 18F-NaF since prior technical and logistic limitations to its routine use are no longer present, and, as a consequence, it is likely that uptake unrelated to bone and non-osseous findings will be encountered more frequently. As a result of tumoral necrosis, soft tissue metastases may demonstrate 18F-NaF avidity due to dystrophic calcification. On the other hand, all non-osseous findings, whether 18F-NaF avid or not, may provide important diagnostic information that may alter the course of the disease, including treatment options. Herein we present a patient with ductal carcinoma of the breast in whom findings unrelated to the skeletal system in 18F-NaF PET/CT altered the treatment strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2008;49(1):68–78.

    Article  PubMed  Google Scholar 

  2. Tateishi U, Morita S, Taguri M, Shizukuishi K, Minamimoto R, Kawaguchi M, et al. A meta-analysis of (18)F-fluoride positron emission tomography for assessment of metastatic bone tumor. Ann Nucl Med. 2010;24(7):523–31.

    Article  PubMed  Google Scholar 

  3. Nishiyama Y, Tateishi U, Shizukuishi K, Shishikura A, Yamazaki E, Shibata H, et al. Role of 18F-fluoride PET/CT in the assessment of multiple myeloma: initial experience. Ann Nucl Med. 2013;27(1):78–83.

    Article  CAS  PubMed  Google Scholar 

  4. Pirayesh E, Rakhshan A, Amoui M, Rakhsha A, Poor AS, Assadi M. Metastasis of femoral osteosarcoma to the abdominal wall detected on 99mTc-MDP skeletal scintigraphy. Ann Nucl Med. 2013. doi:10.1007/s12149-013-0708-6.

    PubMed  Google Scholar 

  5. Basu S, Kembhavi S. Serendipitous observation of hepatic metastases on (18)F-fluoride PET in a patient with infiltrating ductal carcinoma of breast: correlation with contrast enhanced CT. Clin Nucl Med. 2012;37(12):1176–8.

    PubMed  Google Scholar 

  6. Sheth S, Colletti PM. Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans. Clin Nucl Med. 2012;37(5):e110–6.

    Article  PubMed  Google Scholar 

  7. Swiętaszczyk C, Prasad V, Baum RP. Intense 18F-fluoride accumulation in liver metastases from a neuroendocrine tumor after peptide receptor radionuclide therapy. Clin Nucl Med. 2012;37(4):e82–3.

    Article  PubMed  Google Scholar 

  8. Stewart VL, Herling P, Dalinka MK. Calcification in soft tissues. JAMA. 1983;250(1):78–81.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

All authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Serkan Kuyumcu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuyumcu, S., Adalet, I., Isik, E.G. et al. Impact of Nonosseous Findings on 18F-NaF PET/CT in a Patient with Ductal Breast Carcinoma. Nucl Med Mol Imaging 48, 72–74 (2014). https://doi.org/10.1007/s13139-013-0235-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13139-013-0235-3

Keywords

Navigation